In recent years, Polycystic Ovary Syndrome (PCOS) has transformed from a common hormonal disorder into a large-scale public health concern in India. It is affecting millions of women, and PCOS is no long a clinical issue. It is also shaping the future of the gynecology pharma market.
This shift presents both a healthcare challenge and a significant opportunity for the pharmaceutical companies focusing on women’s healthcare.
Understanding the Increase in PCOS Burden in India
PCOS is the most prevalent endocrine disorder among women of reproductive age. Studies suggest that prevalence in India is widely increasing from 3.7% to 22.5% as per the studies of PMC medicine.
Large-scale data indicate that nearly 7% to almost 20% Indian women may be affected. In some urban populations, the numbers are even high with the studies reporting over 17% among the women.
Key reasons behind the surge
- Poor lifestyle and poor dietary habits
- Increase in stress and hormonal imbalance
- Increase in obesity and insulin resistance
- Better awareness and early diagnosis
Why is PCOS a Growing Health Concern?
PCOS is affecting multiple aspects of women’s health, including:
- Irregular menstrual cycle
- Infertility issues
- Acne and excessive hair growth
- Metabolic disorders like diabetes and obesity
Many women are facing conditions like metabolic syndrome, cardiovascular risks, and hormonal imbalances. It also makes PCOS a multi-dimensional health issue. To deal with issues, more women are seeking help for these issues. Additionally, it is also increasing the demand for gynecology treatment.
Impact of PCOS in The Gynae Pharma Market
1. Increase in Demand of Specialized Medicine
There is a growing need for hormonal imbalance therapies, insulin-sensitizing drugs, fertility support medicines, and nutraceutical supplements.
2. Expanding Product Portfolio
Pharma companies are now focusing on developing the target formulation specially designed for PCOS management. It includes combination therapies and lifestyle-support products.
3. Growth of Healthcare
The increasing healthcare needs of the population lead to a healthcare focus on preventive measures instead of treatment methods. The solution consists of three components, which are supplements, early diagnosis kits, and long-term management solutions.
4. Market Growth Opportunity
The Indian gynecology pharmaceutical industry experiences continuous growth because people now understand reproductive disorders, particularly PCOS. The segment shows steady growth because people need better treatment options.
What This Means for Pharma Companies?
The rising PCOS cases force pharmaceutical companies in the gynecology sector to develop new business approaches. Key opportunities:
1. Innovation in Formulations
Companies that develop new, effective, and safe treatments for PCOS will obtain a market advantage through their research investments.
2. Focus on Quality & Compliance
People with PCOS require medications that provide them with effective relief over extended periods of time. The organization must achieve two requirements, which include maintaining high production standards and following all applicable regulations.
3. Patient-Centric Solutions
Modern strategies seek:
- Affordable medicine
- Some of the side effects
- Easy-to-use formulation
Strategic Role of Companies Like Adorshea
Companies like Adorshea in the Infertility Medicines and Gynae Medicine industry are developing their businesses through their work on three specific areas.
The first area focuses on developing high-quality gynecology formulations.
Second is focusing on developing the research-backed infertility and gynecology medicines.
Third area, creating healthcare solutions that remain budget-friendly for customers.
The last one is working on projects that increase the availability of medicines that treat women’s health conditions.
Final Thoughts!
The increasing rates of PCOS in India present an urgent medical issue that will shape the future of the gynecology medicine market. The medical needs of millions of women require ongoing treatment, which will drive the demand for effective, safe, and accessible medical solutions.
Adoreshea is an Infertility Medicines and Gynae Medicine company, we are focusing on fulfilling our duty to create new products and provide educational resources. We are developing high-quality infertility medicines to improve healthcare solutions that benefit women.